News & Events

An easy-to-use device for infant circumcision has proved to be safe in an international randomized controlled clinical trial led by Weill Cornell Medicine physician-scientists. The results suggest that the device could boost efforts to increase circumcision rates and prevent HIV in low-resource settings where early infant circumcision is not widespread. 

The trial, whose results were...

Tampa FL (Sept. 13, 2022) – Artificial intelligence may soon help doctors diagnose and treat diseases, including cancer and depression, based on the sound of a patient’s voice, as 12 leading research institutions launch a landmark National Institutes of Health-funded academic project that may establish voice as a biomarker used in clinical care.

The University of South Florida in Tampa, FL, is the lead institution on the project in collaboration with...

NEW YORK (Sept. 9, 2022)—Weill Cornell Medicine was awarded a $61.9 million grant from the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) to continue funding its Clinical and Translational Science Center (CTSC) until 2027. It is the largest federal grant ever awarded to Weill Cornell Medicine and the fourth consecutive time this initiative has been funded by the NIH, representing...

Immune cells called group 3 innate lymphoid cells (ILC3s) play an essential role in establishing tolerance to symbiotic microbes that dwell in the human gastrointestinal tract, according to a study led by researchers at Weill Cornell Medicine.

The discovery, reported Sept. 7 in Nature, illuminates an important aspect of gut health and mucosal immunity—one that may hold the key to better treatments for inflammatory bowel...

Weill Cornell Medicine has been awarded a five-year, $5 million grant from the National Institutes of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to establish a new multi-institutional center for tuberculosis (TB) research and training the next generation of TB investigators. The New York Tri-Institutional TB Research Advancement Center (TRAC) will provide seed-funding to both early-career and established researchers new to TB science, and extend outreach...

Dr. Gunisha Kaur, an assistant professor of anesthesiology at Weill Cornell Medicine and medical director of the Weill Cornell Center for Human Rights, has been selected as an Emerging Leaders in Health and Medicine (ELHM) Scholar by the National Academy of Medicine.

Dr. Kaur, a respected human rights researcher, was one of 10 ELHM Scholars chosen this year. Established in 2016, the ELHM program annually selects early-...

A new preclinical model for thymic cancer developed by Weill Cornell Medicine investigators has revealed insights into how a common mutation found in thymic epithelial tumors sparks their formation. The model may help speed the development of targeted therapies for cancer of the thymus, a gland that makes immune cells that help protect the body from infections.

In a study published Aug. 29 in the Journal of...

A new study from Weill Cornell Medicine investigators shows that cultural values and social support may influence a caregiver’s burden, self-efficacy and depressive symptoms. These findings suggest interventions aimed at buffering the negative effects of care-related stress should reinforce the importance of social connections. 

In a study reported in the July 2022 issue of the Journals...

When fat accumulates in the liver, the immune system may assault the organ. A new study from Weill Cornell Medicine researchers identifies the molecule that trips these defenses, a discovery that helps to explain the dynamics underlying liver damage that can accompany type 2 diabetes and obesity. 

In a study published Aug. 19 in Science Immunology, researchers mimicked these human metabolic diseases by genetically...

Vaccination with a SARS-CoV-2 mRNA vaccine revealed HIV hiding in immune cells in blood from people with HIV, according to lab research led by Weill Cornell Medicine investigators. The findings, published Aug. 19 in Nature Communications, identify new tools for evaluating treatment approaches in development aimed at curing HIV.

“There is prior knowledge of the flu vaccine, for example, waking up HIV and exposing it to the...

A new preclinical study by Weill Cornell Medicine investigators found that certain bacteria in the gut may reduce susceptibility to SARS-CoV-2 infection, improve the immune response and prevent blood clots that can occur in severe COVID-19 illness. The study, published Aug. 1 in Gut Microbes, suggests that dietary choices may also have the potential to enhance efforts to combat COVID-19 and its complications in...

WATCH the full Class of 2026 White Coat Ceremony on YouTube

Rana Barghout didn’t realize the power of her story until she shared it. It had been five years since she experienced homelessness,...

The discovery of how to shift damaged brain cells from a diseased state into a healthy one poses a new potential path to treating Alzheimer’s and other forms of dementia, according to a new collaborative study from researchers at UC San Francisco and Weill Cornell Medicine.

The research focuses on microglia, cells that stabilize the brain by clearing out damaged neurons and the protein plaques often associated with dementia and other brain diseases.

“These cells are understudied...

A new analysis shows that a combination of two anti-platelets drugs can benefit patients after the most common type of cardiac surgery — while also increasing the risk of potentially dangerous bleeding. This double-edged finding from Weill Cornell Medicine and NewYork-Presbyterian investigators suggests physicians should carefully weigh the use of these medications after this procedure. 

In an analysis...

Disruption of the circadian clocks that keep the body and its cells entrained to the 24-hour day-night cycle plays a critical role in weight gain, according to a pair of studies by Weill Cornell Medicine investigators.  

One study, published June 27, in Cell Reports revealed that stress caused by chronically administering glucocorticoid stress hormones and disturbing the normal daily cycle of release...

NEW YORK (July 28, 2022)—Dr. Jedd Wolchok, an internationally acclaimed medical oncologist whose innovations in immunotherapy have revolutionized melanoma treatment, has been recruited as the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, effective Sept. 12.

In his new role, Dr. Wolchok will lead an expansive,...

After experiencing a rapid expansion early in the COVID-19 pandemic, a new survey indicates that telemedicine is now widely viewed as an effective means for delivering care.

In results published online on June 15 in NEJM Catalyst Innovations in Care Delivery, a majority of respondents credited telemedicine with improving patient health, providing good quality care and increasing access for vulnerable populations....

Vaccination against COVID-19 had no impact on the health of placentas in pregnant women, according to new research by pathologists at Weill Cornell Medicine and NewYork-Presbyterian. The findings, published June 27 as a research letter in the American Journal of Obstetrics & Gynecology, further emphasize the safety of vaccination during pregnancy for babies and pregnant women, the investigators note.

Most...

Antibodies that summon virus-engulfing white blood cells may play an important role in protecting infants from potentially serious congenital infection with human cytomegalovirus (HCMV), according to a study led by an investigator at Weill Cornell Medicine and NewYork-Presbyterian.

The study, which appeared June 28 in the Journal of Clinical Investigation, was the most comprehensive analysis of its kind to date in HCMV research....

Dr. Iliyan D. Iliev, an associate professor of immunology in medicine in the Division of Gastroenterology and Hepatology and a member of the Jill Roberts Institute for Research in Inflammatory Bowel Disease at Weill Cornell Medicine, has been awarded a five-year, $1.25 million CRI Lloyd J. Old STAR (Scientists Taking Risks) Program grant from Cancer Research Institute (CRI).